Cargando…

An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rising morbidity amongst hospitalized patients. Whilst clinical protocols for the management of individual DRESS cases have been well established, determination of potential prevention of these cases by utilizing novel “avoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danjuma, Mohammed Ibn-Mas’ud, Naseralallah, Lina Mohammad Ahmad, AbouJabal, Bodoor, Mohamed, Mouhand Faisal, Abubeker, Ibrahim Y., Jabbar, Layla Abdul, Elzouki, Abdelnaser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429441/ https://www.ncbi.nlm.nih.gov/pubmed/34504198 http://dx.doi.org/10.1038/s41598-021-97381-6

Ejemplares similares

What is polypharmacy in people living with HIV/AIDS? A systematic review
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2022)

The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome
por: Naseralallah, Lina Mohammad, et al.
Publicado: (2022)

Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2019)

The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021)

Median arcuate ligament syndrome masquerading as mesenteric angina
por: Chapra, Ammar, et al.
Publicado: (2021)

Critical care tele‐pharmacy services during COVID‐19 pandemic: A qualitative exploration of healthcare practitioners' perceptions
por: Isleem, Nour, et al.
Publicado: (2022)

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systematic review and network meta-analysis using a generalized pairwise modeling methodology
por: Danjuma, Mohammed ibn-Mas’ud, et al.
Publicado: (2020)

Prevalence and global trends of polypharmacy in patients with chronic liver disease: A systematic review and meta-analysis
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2023)

An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

Perceived Barriers of Incident Reporting Among Internists: Results from Hamad Medical Corporation in Qatar
por: Mohamed, Mouhand F.H., et al.
Publicado: (2021)

Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data
por: Alalawneh, Majdoleen, et al.
Publicado: (2023)

Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS)
por: Gill, Shaman, et al.
Publicado: (2013)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in children
por: Francesca, Mori, et al.
Publicado: (2019)

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis
por: Naseralallah, Lina, et al.
Publicado: (2023)

Griseofulvin associated with drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Maiolo, Corinne, et al.
Publicado: (2016)

Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Sharpe, Alexis, et al.
Publicado: (2019)

Valproate-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Dwivedi, Arun Kumar, et al.
Publicado: (2018)

Editorial: Updates in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Janela, Baptiste, et al.
Publicado: (2023)

Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses
por: Danjuma, Mohammed I., et al.
Publicado: (2023)

Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis
por: Danjuma, Mohammed I., et al.
Publicado: (2022)

Efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type II diabetes: A protocol for systematic review of randomised controlled clinical trials utilising a generalised pairwise modelling methodology
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2019)

Severe ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Picard, Matthieu, et al.
Publicado: (2011)

Eosinophilia in pre-anesthetic assessment: A guide to diagnosis of DRESS syndrome
por: Bansal, Shivendu, et al.
Publicado: (2013)

Ivermectin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
por: Kerneuzet, Ines, et al.
Publicado: (2018)

Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Jörg, Lukas, et al.
Publicado: (2020)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation
por: Cho, Ara, et al.
Publicado: (2021)

Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Due to Vancomycin
por: Kulkarni, Mugdha P, et al.
Publicado: (2022)

Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2021)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Teicoplanin: A Case Report
por: Ebrahimpour, Sholeh, et al.
Publicado: (2016)

Drug reaction with eosinophilia and systemic symptoms (DRESS) with severe and atypical lung involvement
por: Guerrero Gómez, Diego Armando, et al.
Publicado: (2020)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Associated with Mycoplasma pneumoniae Infection
por: Shalom, Guy, et al.
Publicado: (2020)

Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)—Readdressing the DReSS
por: Stirton, Hannah, et al.
Publicado: (2022)

DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin
por: O'Meara, Paloma, et al.
Publicado: (2011)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): clinco-histopathologic studies of 45 cases
por: Skowron, Francois, et al.
Publicado: (2014)

A Case of the Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Following Isoniazid Treatment
por: Lee, Jin-Yong, et al.
Publicado: (2015)

Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome)
por: Mangana, Joanna, et al.
Publicado: (2017)

Case report: Drug reaction with eosinophilia and systemic symptoms (DRESS)-induced hemophagocytic disorder
por: Pope, Eliza I., et al.
Publicado: (2022)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses
por: Ramirez, Giuseppe A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ls40rdjv7vk76roqc3ksivio3o